BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 34944644)

  • 1. The Functional Role of IgA in the IgM/IgA-Enriched Immunoglobulin Preparation Trimodulin.
    Bohländer F; Weißmüller S; Riehl D; Gutscher M; Schüttrumpf J; Faust S
    Biomedicines; 2021 Dec; 9(12):. PubMed ID: 34944644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomodulation: Immunoglobulin Preparations Suppress Hyperinflammation in a COVID-19 Model
    Bohländer F; Riehl D; Weißmüller S; Gutscher M; Schüttrumpf J; Faust S
    Front Immunol; 2021; 12():700429. PubMed ID: 34177967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Dual Role of a Polyvalent IgM/IgA-Enriched Immunoglobulin Preparation in Activating and Inhibiting the Complement System.
    Schmidt C; Weißmüller S; Bohländer F; Germer M; König M; Staus A; Wartenberg-Demand A; Heinz CC; Schüttrumpf J
    Biomedicines; 2021 Jul; 9(7):. PubMed ID: 34356880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunomodulating activity of trimodulin (polyvalent IgM, IgA, IgG solution): a post hoc analysis of the phase II CIGMA trial.
    Singer M; Torres A; Heinz CC; Weißmüller S; Staus A; Kistner S; Jakubczyk K; Häder T; Langohr P; Wartenberg-Demand A; Schüttrumpf J; Vincent JL; Welte T
    Crit Care; 2023 Nov; 27(1):436. PubMed ID: 37946226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study).
    Welte T; Dellinger RP; Ebelt H; Ferrer M; Opal SM; Singer M; Vincent JL; Werdan K; Martin-Loeches I; Almirall J; Artigas A; Ignacio Ayestarán J; Nuding S; Ferrer R; Sirgo Rodríguez G; Shankar-Hari M; Álvarez-Lerma F; Riessen R; Sirvent JM; Kluge S; Zacharowski K; Bonastre Mora J; Lapp H; Wöbker G; Achtzehn U; Brealey D; Kempa A; Sánchez García M; Brederlau J; Kochanek M; Reschreiter HP; Wise MP; Belohradsky BH; Bobenhausen I; Dälken B; Dubovy P; Langohr P; Mayer M; Schüttrumpf J; Wartenberg-Demand A; Wippermann U; Wolf D; Torres A
    Intensive Care Med; 2018 Apr; 44(4):438-448. PubMed ID: 29632995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent Fc Receptor Signaling by IgA Leads to Superior Killing of Cancer Cells by Neutrophils Compared to IgG.
    Brandsma AM; Bondza S; Evers M; Koutstaal R; Nederend M; Jansen JHM; Rösner T; Valerius T; Leusen JHW; Ten Broeke T
    Front Immunol; 2019; 10():704. PubMed ID: 31031746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-inflammatory role of the IgA Fc receptor (CD89): from autoimmunity to therapeutic perspectives.
    Ben Mkaddem S; Rossato E; Heming N; Monteiro RC
    Autoimmun Rev; 2013 Apr; 12(6):666-9. PubMed ID: 23201915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical Characterization of a New 10% IVIG Preparation [IgG Next Generation (BT595)/Yimmugo
    Duellberg C; Hannappel A; Kistner S; Maneg O
    Drugs R D; 2023 Sep; 23(3):245-255. PubMed ID: 37466834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgM and IgA rheumatoid factors purified from rheumatoid arthritis sera boost the Fc receptor- and complement-dependent effector functions of the disease-specific anti-citrullinated protein autoantibodies.
    Anquetil F; Clavel C; Offer G; Serre G; Sebbag M
    J Immunol; 2015 Apr; 194(8):3664-74. PubMed ID: 25769920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of Arthritis by Human Monomeric IgA Through the Receptor-Mediated SH2 Domain-Containing Phosphatase 1 Inhibitory Pathway.
    Rossato E; Ben Mkaddem S; Kanamaru Y; Hurtado-Nedelec M; Hayem G; Descatoire V; Vonarburg C; Miescher S; Zuercher AW; Monteiro RC
    Arthritis Rheumatol; 2015 Jul; 67(7):1766-77. PubMed ID: 25833812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgA Complexes in Plasma and Synovial Fluid of Patients with Rheumatoid Arthritis Induce Neutrophil Extracellular Traps via FcαRI.
    Aleyd E; Al M; Tuk CW; van der Laken CJ; van Egmond M
    J Immunol; 2016 Dec; 197(12):4552-4559. PubMed ID: 27913645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of antibody-dependent cell-mediated cytotoxicity by endowing IgG with FcαRI (CD89) binding.
    Borrok MJ; Luheshi NM; Beyaz N; Davies GC; Legg JW; Wu H; Dall'Acqua WF; Tsui P
    MAbs; 2015; 7(4):743-51. PubMed ID: 25970007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgA and FcαRI: Pathological Roles and Therapeutic Opportunities.
    Breedveld A; van Egmond M
    Front Immunol; 2019; 10():553. PubMed ID: 30984170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide mimetics of immunoglobulin A (IgA) and FcαRI block IgA-induced human neutrophil activation and migration.
    Heineke MH; van der Steen LPE; Korthouwer RM; Hage JJ; Langedijk JPM; Benschop JJ; Bakema JE; Slootstra JW; van Egmond M
    Eur J Immunol; 2017 Oct; 47(10):1835-1845. PubMed ID: 28736835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgA Fc receptors.
    Monteiro RC; Van De Winkel JG
    Annu Rev Immunol; 2003; 21():177-204. PubMed ID: 12524384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyvalent Immunoglobulin Preparations Inhibit Pneumolysin-Induced Platelet Destruction.
    Wiebe F; Handtke S; Wesche J; Schnarre A; Palankar R; Wolff M; Jahn K; Voß F; Weißmüller S; Schüttrumpf J; Greinacher A; Hammerschmidt S
    Thromb Haemost; 2022 Jul; 122(7):1147-1158. PubMed ID: 34918314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoglobulin A: magic bullet or Trojan horse?
    Heineke MH; van Egmond M
    Eur J Clin Invest; 2017 Feb; 47(2):184-192. PubMed ID: 28024097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FcalphaRI (CD89) as a novel trigger molecule for bispecific antibody therapy.
    Valerius T; Stockmeyer B; van Spriel AB; Graziano RF; van den Herik-Oudijk IE; Repp R; Deo YM; Lund J; Kalden JR; Gramatzki M; van de Winkel JG
    Blood; 1997 Dec; 90(11):4485-92. PubMed ID: 9373259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulatory effects of different intravenous immunoglobulin preparations in chronic lymphocytic leukemia.
    Colado A; Elías EE; Sarapura Martínez VJ; Cordini G; Morande P; Bezares F; Giordano M; Gamberale R; Borge M
    Sci Rep; 2021 Jun; 11(1):12926. PubMed ID: 34155276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Broadly Neutralizing Hemagglutinin Stalk-Specific Antibodies Induce Potent Phagocytosis of Immune Complexes by Neutrophils in an Fc-Dependent Manner.
    Mullarkey CE; Bailey MJ; Golubeva DA; Tan GS; Nachbagauer R; He W; Novakowski KE; Bowdish DM; Miller MS; Palese P
    mBio; 2016 Oct; 7(5):. PubMed ID: 27703076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.